200831_Appendix 4E & Preliminary Final Report Category: News & Announcements 2020By PharmAust31/08/2020Related postsDecember 31, Top 20 Shareholders04/01/2021December 23, PharmAust Commences MPL Manufacture for Human Clinical Trials23/12/2020December 22, PharmAust Set to Commence Phase IIb Anticancer Canine Trial22/12/2020December 21, Epichem Awarded DNDi Extension21/12/2020December 4, Issued Capital04/12/2020November 30, Top 20 Shareholders01/12/2020
